Parallax Volatility Advisers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.61M | Buy |
132,100
+38,200
| +41% | +$1.02M | 0.01% | 657 |
|
|
2025
Q4 | $2.34M | Sell |
93,900
-123,500
| -57% | -$3.11M | ﹤0.01% | 900 |
|
|
2025
Q3 | $5.54M | Sell |
217,400
-346,000
| -61% | -$8.54M | 0.01% | 650 |
|
|
2025
Q2 | $13.7M | Sell |
563,400
-189,300
| -25% | -$4.41M | 0.03% | 346 |
|
|
2025
Q1 | $19.1M | Sell |
752,700
-890,900
| -54% | -$23.3M | 0.05% | 280 |
|
|
2024
Q4 | $43.6M | Buy |
1,643,600
+388,300
| +31% | +$10.5M | 0.08% | 177 |
|
|
2024
Q3 | $36.3M | Sell |
1,255,300
-333,800
| -21% | -$9.74M | 0.07% | 215 |
|
|
2024
Q2 | $44.5M | Sell |
1,589,100
-554,100
| -26% | -$15.3M | 0.1% | 151 |
|
|
2024
Q1 | $59.5M | Buy |
2,143,200
+625,000
| +41% | +$17.3M | 0.13% | 140 |
|
|
2023
Q4 | $43.7M | Buy |
1,518,200
+703,100
| +86% | +$21.3M | 0.09% | 207 |
|
|
2023
Q3 | $27M | Sell |
815,100
-265,400
| -25% | -$9.39M | 0.06% | 249 |
|
|
2023
Q2 | $39.6M | Sell |
1,080,500
-59,300
| -5% | -$2.31M | 0.09% | 194 |
|
|
2023
Q1 | $46.5M | Buy |
1,139,800
+589,700
| +107% | +$25.5M | 0.1% | 206 |
|
|
2022
Q4 | $28.2M | Sell |
550,100
-135,200
| -20% | -$6.48M | 0.04% | 420 |
|
|
2022
Q3 | $30M | Sell |
685,300
-497,900
| -42% | -$24.2M | 0.05% | 412 |
|
|
2022
Q2 | $62M | Sell |
1,183,200
-196,600
| -14% | -$10M | 0.06% | 229 |
|
|
2022
Q1 | $71.4M | Sell |
1,379,800
-2,049,400
| -60% | -$106M | 0.04% | 197 |
|
|
2021
Q4 | $202M | Sell |
3,429,200
-1,012,400
| -23% | -$50.2M | 0.24% | 47 |
|
|
2021
Q3 | $191M | Buy |
4,441,600
+2,411,000
| +119% | +$107M | 0.18% | 67 |
|
|
2021
Q2 | $79.5M | Buy |
2,030,600
+282,300
| +16% | +$11M | 0.11% | 129 |
|
|
2021
Q1 | $63.3M | Sell |
1,748,300
-1,939,400
| -53% | -$68.9M | 0.14% | 121 |
|
|
2020
Q4 | $136M | Sell |
3,687,700
-1,423,251
| -28% | -$52.2M | 0.14% | 111 |
|
|
2020
Q3 | $178M | Buy |
5,110,951
+1,076,134
| +27% | +$37.7M | 0.13% | 127 |
|
|
2020
Q2 | $125M | Buy |
4,034,817
+929,417
| +30% | +$31.6M | 0.15% | 114 |
|
|
2020
Q1 | $96.2M | Buy |
3,105,400
+1,639,708
| +112% | +$55.9M | 0.12% | 116 |
|
|
2019
Q4 | $54.5M | Sell |
1,465,692
-365,422
| -20% | -$13M | 0.06% | 203 |
|
|
2019
Q3 | $62.4M | Sell |
1,831,114
-1,536,416
| -46% | -$55.9M | 0.07% | 156 |
|
|
2019
Q2 | $138M | Buy |
3,367,530
+1,198,925
| +55% | +$47.6M | 0.15% | 72 |
|
|
2019
Q1 | $87.4M | Buy |
2,168,605
+1,500,474
| +225% | +$60.1M | 0.1% | 95 |
|
|
2018
Q4 | $27.7M | Buy |
668,131
+484,524
| +264% | +$20.1M | 0.04% | 283 |
|
|
2018
Q3 | $7.68M | Sell |
183,607
-1,023,012
| -85% | -$39.4M | 0.01% | 556 |
|
|
2018
Q2 | $41.5M | Sell |
1,206,619
-898,008
| -43% | -$30.7M | 0.06% | 141 |
|
|
2018
Q1 | $70.9M | Buy |
2,104,627
+1,577,627
| +299% | +$54.2M | 0.1% | 104 |
|
|
2017
Q4 | $18.1M | Buy |
527,000
+157,257
| +43% | +$5.36M | 0.02% | 271 |
|
|
2017
Q3 | $12.5M | Buy |
369,743
+158,943
| +75% | +$5.11M | 0.02% | 348 |
|
|
2017
Q2 | $6.72M | Buy |
210,800
+52,700
| +33% | +$1.66M | 0.01% | 496 |
|
|
2017
Q1 | $5.13M | Sell |
158,100
-709,658
| -82% | -$22.4M | 0.01% | 574 |
|
|
2016
Q4 | $26.7M | Buy |
867,758
+244,212
| +39% | +$7.46M | 0.05% | 231 |
|
|
2016
Q3 | $20M | Sell |
623,546
-430,770
| -41% | -$14.4M | 0.04% | 280 |
|
|
2016
Q2 | $35.2M | Sell |
1,054,316
-18,212,804
| -95% | -$581M | 0.07% | 189 |
|
|
2016
Q1 | $542M | Buy |
19,267,120
+18,307,242
| +1,907% | +$523M | 1.19% | 9 |
|
|
2015
Q4 | $29.4M | Buy |
959,878
+317,781
| +49% | +$10M | 0.06% | 209 |
|
|
2015
Q3 | $19.1M | Sell |
642,097
-871,342
| -58% | -$27.9M | 0.04% | 275 |
|
|
2015
Q2 | $48.1M | Sell |
1,513,439
-792,502
| -34% | -$25.8M | 0.1% | 131 |
|
|
2015
Q1 | $76.1M | Sell |
2,305,941
-1,618,206
| -41% | -$51.4M | 0.18% | 90 |
|
|
2014
Q4 | $116M | Sell |
3,924,147
-364,474
| -8% | -$10.5M | 0.34% | 55 |
|
|
2014
Q3 | $120M | Buy |
4,288,621
+3,941,433
| +1,135% | +$111M | 0.38% | 44 |
|
|
2014
Q2 | $9.78M | Sell |
347,188
-110,143
| -24% | -$3.14M | 0.04% | 319 |
|
|
2014
Q1 | $13.9M | Sell |
457,331
-814,847
| -64% | -$24.3M | 0.08% | 196 |
|
|
2013
Q4 | $37M | Sell |
1,272,178
-49,854
| -4% | -$1.45M | 0.18% | 120 |
|
|
2013
Q3 | $36M | Sell |
1,322,032
-656,326
| -33% | -$17.9M | 0.19% | 103 |
|
|
2013
Q2 | $52.6M | Buy |
+1,978,358
| New | +$54.7M | 0.25% | 74 |
|
Other funds holding PFE
VCM
VPM
Parallax Volatility Advisers's PFE Position: Q1 2026 in Review
Parallax Volatility Advisers opened a new position in Pfizer (PFE) in Q1 2026: 7 shares worth $197. The stake represents ﹤0.01% of the portfolio and ranks #1401 among its holdings. This is a return to the name: Parallax Volatility Advisers previously reported a position in PFE as recently as Q2 2025.
Parallax Volatility Advisers first reported a position in PFE in Q2 2013 and has held it in 35 quarters since. The position peaked at $46.9M in Q3 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Parallax Volatility Advisers held 7 shares of Pfizer worth $197 as of Q1 2026.
- Pfizer was a new Parallax Volatility Advisers position in Q1 2026.
- Pfizer made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #1401 holding.
- Parallax Volatility Advisers first reported a position in Pfizer in Q2 2013 and has held it in 35 quarters since.
- Parallax Volatility Advisers's Pfizer position peaked at $46.9M in Q3 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.